Efficacy and toxicity of infradiaphragmal radiotherapy fields in lymphoma patients: a single-centre experience

[1]  S. Milgrom,et al.  Clinical Outcomes Confirm Conjecture: Modern Radiation Therapy Reduces the Risk of Late Toxicity in Survivors of Hodgkin Lymphoma. , 2021, International journal of radiation oncology, biology, physics.

[2]  A. Fiorentino,et al.  The impact of modern radiotherapy on radiation-induced late sequelae: focus on early-stage mediastinal classical Hodgkin Lymphoma. A critical review by the Young Group of the Italian Association of Radiotherapy and Clinical Oncology (AIRO). , 2021, Critical reviews in oncology/hematology.

[3]  P. Nathan,et al.  Impact of Risk-Adapted Therapy for Pediatric Hodgkin Lymphoma on Risk of Long-Term Morbidity: A Report From the Childhood Cancer Survivor Study , 2021, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[4]  P. Hoskin,et al.  4 Gy versus 24 Gy radiotherapy for follicular and marginal zone lymphoma (FoRT): long-term follow-up of a multicentre, randomised, phase 3, non-inferiority trial. , 2021, The Lancet. Oncology.

[5]  U. Ricardi,et al.  Proton Therapy For Lymphomas: Current State Of The Art , 2019, OncoTargets and therapy.

[6]  H. Eich,et al.  Definitive radiotherapy for localized follicular lymphoma staged by 18F-FDG PET-CT: a collaborative study by ILROG. , 2019, Blood.

[7]  F. Šantek,et al.  INFRADIAPHRAGMAL RADIOTHERAPY IN PATIENTS WITH LYMPHOMA: VOLUME DEFINITION AND SIDE EFFECTS , 2018, Acta clinica Croatica.

[8]  H. Eich,et al.  The Role of Radiation Therapy in Patients With Relapsed or Refractory Hodgkin Lymphoma: Guidelines From the International Lymphoma Radiation Oncology Group. , 2018, International journal of radiation oncology, biology, physics.

[9]  Michael Hauptmann,et al.  Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma. , 2016, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[10]  H. Eich,et al.  Überlebensvorteil durch konsolidierende Strahlentherapie bei Patienten mit diffusem großzelligen B‑Zell-Lymphom in den Frühstadien , 2016, Strahlentherapie und Onkologie.

[11]  Won Hoon Choi,et al.  Evolving Clinical Cancer Radiotherapy: Concerns Regarding Normal Tissue Protection and Quality Assurance , 2016, Journal of Korean medical science.

[12]  L. Specht.  Does Radiation Have a Role in Advanced Stage Hodgkin’s or Non-Hodgkin Lymphoma? , 2016, Current Treatment Options in Oncology.

[13]  J. Connors,et al.  Secondary Breast Cancer Risk by Radiation Volume in Women With Hodgkin Lymphoma. , 2015, International journal of radiation oncology, biology, physics.

[14]  S. Beriwal,et al.  Treatment Selection and Survival Outcomes in Early-Stage Diffuse Large B-Cell Lymphoma: Do We Still Need Consolidative Radiotherapy? , 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[15]  G. Follows,et al.  Guidelines for the first line management of classical Hodgkin lymphoma , 2014, British journal of haematology.

[16]  A. Ng,et al.  Modern radiation therapy for nodal non-Hodgkin lymphoma-target definition and dose guidelines from the International Lymphoma Radiation Oncology Group. , 2014, International journal of radiation oncology, biology, physics.

[17]  C. Rübe,et al.  Role of radiotherapy to bulky disease in elderly patients with aggressive B-cell lymphoma. , 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[18]  C. Flowers,et al.  Patterns of failure in advanced stage diffuse large B-cell lymphoma patients after complete response to R-CHOP immunochemotherapy and the emerging role of consolidative radiation therapy. , 2013, International journal of radiation oncology, biology, physics.

[19]  A. Ng,et al.  Clinical Investigation : Lymphoma Low-Dose Involved-Field Radiation in the Treatment of Non-Hodgkin Lymphoma : Predictors of Response and Treatment Failure , 2022 .

[20]  R. Coleman,et al.  Impact of consolidation radiation therapy in stage III-IV diffuse large B-cell lymphoma with negative post-chemotherapy radiologic imaging. , 2012, International journal of radiation oncology, biology, physics.

[21]  P. Hoskin,et al.  Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: a randomised phase III trial. , 2011, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[22]  Christine F. Wogan,et al.  Benefit of consolidative radiation therapy in patients with diffuse large B-cell lymphoma treated with R-CHOP chemotherapy. , 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[23]  T. Pugh,et al.  Improved survival in patients with early stage low‐grade follicular lymphoma treated with radiation , 2010, Cancer.

[24]  R. Gascoyne,et al.  Long‐term outcomes for patients with limited stage follicular lymphoma , 2010, Cancer.

[25]  X Allen Li,et al.  Radiation-associated kidney injury. , 2010, International journal of radiation oncology, biology, physics.

[26]  C. Flowers,et al.  Does the addition of involved field radiotherapy to high-dose chemotherapy and stem cell transplantation improve outcomes for patients with relapsed/refractory Hodgkin lymphoma? , 2009, International journal of radiation oncology, biology, physics.

[27]  Michael C. Joiner,et al.  Basic Clinical Radiobiology , 2009 .

[28]  M. Gospodarowicz.  Radiotherapy in non-Hodgkin lymphomas. , 2008, Annals of oncology : official journal of the European Society for Medical Oncology.

[29]  G. Chahine,et al.  Salvage abdominal irradiation for refractory non-Hodgkin's lymphoma. , 2007, Journal of cancer research and therapeutics.

[30]  T. Molina,et al.  ACVBP versus CHOP plus radiotherapy for localized aggressive lymphoma. , 2005, The New England journal of medicine.

[31]  J. Earle,et al.  Chemotherapy with or without radiotherapy in limited-stage diffuse aggressive non-Hodgkin's lymphoma: Eastern Cooperative Oncology Group study 1484. , 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[32]  G. Chahine,et al.  Abdominal irradiation after chemotherapy in non-Hodgkin's lymphoma: review of 32 patients. , 2003, Molecular immunology.

[33]  A. Hart,et al.  High response rates and lasting remissions after low-dose involved field radiotherapy in indolent lymphomas. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[34]  R. Haas,et al.  HOVON 47/EORTC 20013: chlorambucil vs 2×2 Gy involved field radiotherapy in stage III/IV previously untreated follicular lymphoma patients , 2003, Annals of Hematology.

[35]  G. Ceresoli,et al.  Consolidation Radiotherapy to Bulky or Semibulky Lesions in the Management of Stage III–IV Diffuse Large B Cell Lymphomas , 2000, Oncology.

[36]  R. Fisher,et al.  Chemotherapy alone compared with chemotherapy plus radiotherapy for localized intermediate- and high-grade non-Hodgkin's lymphoma. , 1998, The New England journal of medicine.

[37]  P. Moreau,et al.  Long-term results of total abdominopelvic irradiation in non-Hodgkin's lymphomas after failure of chemotherapy. , 1998, International journal of radiation oncology, biology, physics.

[38]  J. Corry,et al.  Salvage radiotherapy for Hodgkin's disease following chemotherapy failure. , 1997, International journal of radiation oncology, biology, physics.

[39]  A. Avilés,et al.  Adjuvant radiotherapy to sites of previous bulky disease in patients stage IV diffuse large cell lymphoma. , 1994, International journal of radiation oncology, biology, physics.

[40]  R. Valicenti,et al.  Non-Hodgkin lymphoma: whole-abdomen irradiation as an adjuvant to chemotherapy. , 1994, Radiology.

[41]  D. Longo.  Combined modality therapy for localized aggressive lymphoma: enough or too much? , 1989, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  E. Jaffe,et al.  Residual abdominal masses in aggressive non-Hodgkin's lymphoma after combination chemotherapy: significance and management. , 1988, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[43]  L. Coia,et al.  Complications from large field intermediate dose infradiaphragmatic radiation: an analysis of the patterns of care outcome studies for Hodgkin's disease and seminoma. , 1988, International journal of radiation oncology, biology, physics.

[44]  L. Specht,et al.  Hodgkin's disease stages I and II with infradiaphragmatic presentation: A rare and prognostically unfavourable combination * , 1988, European journal of haematology.

[45]  M. Kuentz,et al.  Intestinal complications of wide field abdominal irradiation for lymphoma. , 1985, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[46]  J. Cosset,et al.  Radiation injurie of the gastrointestinal tract in Hodgkin's disease: The role of exploratory laparotomy and fractionation , 1984 .

[47]  Z. Fuks,et al.  Abdominal irradiation in non‐Hodgkin's lymphomas , 1976, Cancer.

[48]  L. Delclos,et al.  WHOLE ABDOMINAL IRRADIATION BY COBALT-60 MOVING-STRIP TECHNIC. , 1963, Radiology.

[49]  John McGrath,et al.  Hodgkin’s Disease , 1933, JAMA.

[50]  U. Ricardi,et al.  Potential Benefit of Involved‐Field Radiotherapy for Patients With Relapsed‐Refractory Hodgkin's Lymphoma With Incomplete Response Before Autologous Stem Cell Transplantation , 2017, Clinical Lymphoma, Myeloma & Leukemia.

[51]  L. Harrison,et al.  Association of intensity-modulated radiation therapy on overall survival for patients with Hodgkin lymphoma. , 2016, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[52]  M. Colgan,et al.  Subdiaphragmatic Hodgkin's disease: the University of Florida experience. , 2002, International journal of radiation oncology, biology, physics.

[53]  A. Niemierko,et al.  Modeling of normal tissue response to radiation: the critical volume model. , 1993, International journal of radiation oncology, biology, physics.